NewYork-Presbyterian / Weill Cornell Medical Center is a clinical research site located in New York, New York, United States 10065.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
NewYork-Presbyterian / Weill Cornell Medical Center has participated in 1 clinical trials.
Therapeutic areas: Relapsed Acute Myeloid Leukemia (AML), Refractory Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS).
Sponsors: Opna Bio LLC.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NewYork-Presbyterian / Weill Cornell Medical Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NewYork-Presbyterian / Weill Cornell Medical Center has 1 clinical trials on record. Their work covers Relapsed Acute Myeloid Leukemia (AML), Refractory Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS).
NewYork-Presbyterian / Weill Cornell Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.